Cargando…

Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43(A315T) mouse model: A PET-MR study

Currently TAR DNA binding protein 43 (TDP-43) pathology, underlying Amyotrophic Lateral Sclerosis (ALS), remains poorly understood which hinders both clinical diagnosis and drug discovery efforts. To better comprehend the disease pathophysiology, positron emission tomography (PET) and multi-parametr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weerasekera, Akila, Crabbé, Melissa, Tomé, Sandra O., Gsell, Willy, Sima, Diana, Casteels, Cindy, Dresselaers, Tom, Deroose, Christophe, Van Huffel, Sabine, Rudolf Thal, Dietmar, Van Damme, Philip, Himmelreich, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352080/ https://www.ncbi.nlm.nih.gov/pubmed/32653817 http://dx.doi.org/10.1016/j.nicl.2020.102327

Ejemplares similares

Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1(G93A) mouse model: A (1)H-magnetic resonance spectroscopic study
por: Weerasekera, A., et al.
Publicado: (2018)

Neuronal overexpression of hTDP-43 in Caenorhabditis elegans impairs motor function
por: Koopman, Mandy, et al.
Publicado: (2023)

Neuronal overexpression of hTDP-43 in Caenorhabditis elegans mimics the cellular pathology commonly observed in TDP-43 proteinopathies
por: Koopman, Mandy, et al.
Publicado: (2023)

mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms
por: Scherz, Barbara, et al.
Publicado: (2018)

Neuronal overexpression of hTDP-43 in Caenorhabditis elegans impairs different neuronally controlled behaviors and decreases fecundity
por: Koopman, Mandy, et al.
Publicado: (2023)

CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression
por: Riva, Matteo, et al.
Publicado: (2019)

Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice
por: Herdewyn, Sarah, et al.
Publicado: (2014)

Ozone modified hypothalamic signaling enhancing thermogenesis in the TDP-43(A315T) transgenic model of Amyotrophic Lateral Sclerosis
por: Rodríguez-Sánchez, Sara, et al.
Publicado: (2022)

The Human Tyrosyl-DNA Phosphodiesterase 1 (hTdp1) Inhibitor NSC120686 as an Exploratory Tool to Investigate Plant Tdp1 Genes
por: Macovei, Anca, et al.
Publicado: (2018)

Increased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis
por: Dang, Theresa N. T., et al.
Publicado: (2014)

TDP-43 pathology is associated with increased tau burdens and seeding
por: Tomé, Sandra O., et al.
Publicado: (2023)

Estrogen Enhances Dendrite Spine Function and Recovers Deficits in Neuroplasticity in the prpTDP-43(A315T) Mouse Model of Amyotrophic Lateral Sclerosis
por: Handley, Emily E., et al.
Publicado: (2022)

Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
por: Tomé, Sandra O., et al.
Publicado: (2020)

Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43(A315T) ALS/FTD mouse model
por: Bargsted, Leslie, et al.
Publicado: (2017)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)

Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
por: Oiwa, Kotaro, et al.
Publicado: (2023)

TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014)

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020)

TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Bright, Fiona, et al.
Publicado: (2021)

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
por: Williams, Stephanie M., et al.
Publicado: (2017)

Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2017)

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis
por: Beyer, Léon, et al.
Publicado: (2020)

Intracellular Conformation of Amyotrophic Lateral Sclerosis-Causative TDP-43
por: Kitamura, Akira, et al.
Publicado: (2023)

Frontotemporal Lobar Degeneration Case with an N-Terminal TUBA4A Mutation Exhibits Reduced TUBA4A Levels in the Brain and TDP-43 Pathology
por: Van Schoor, Evelien, et al.
Publicado: (2022)

TDP-43 is intercellularly transmitted across axon terminals
por: Feiler, Marisa S., et al.
Publicado: (2015)

Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2018)

ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization
por: Tazelaar, Gijs H P, et al.
Publicado: (2020)

Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice
por: Beel, Sander, et al.
Publicado: (2018)

TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis
por: Guerreiro, Rita J., et al.
Publicado: (2008)

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
por: Prasad, Archana, et al.
Publicado: (2019)

TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
por: Nielsen, Anne Kallehauge, et al.
Publicado: (2020)

Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology
por: Murakami, Aya, et al.
Publicado: (2022)

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022)

Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
por: Rutherford, Nicola J., et al.
Publicado: (2008)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis
por: Cykowski, Matthew D, et al.
Publicado: (2014)

Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
por: Kametani, Fuyuki, et al.
Publicado: (2016)

Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
por: Jeon, Gye Sun, et al.
Publicado: (2018)

Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis
por: Floare, Mara-Luciana, et al.
Publicado: (2020)

Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations
por: Konopka, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_unsa1kdusf63b34je7qee16rr3